MHRA’s New Falsified Medicines Strategy Takes Aim at Internet

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) unveiled a new anti-counterfeiting strategy that builds off a 2007 strategy with increased international collaborations to fight the expanding risk of fake drugs online. The new strategy will focus on communication and collaboration to prevent counterfeit drugs reaching patients, timely response to incidents and prosecution of individuals who manufacture, distribute and supply falsified drugs.
International Pharmaceutical Regulatory Monitor